Scholar Rock Holding Corp. (SRRK)

44.33 -0.91 (-2.01%) USD  |  NASDAQ  |  Dec 16, 16:00
44.32 -0.01 (-0.02%) After-Hours: 20:00
More

Scholar Rock Research and Development Expense (Annual): 182.61M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for SRRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 4.624B
Mersana Therapeutics, Inc. 73.02M
ETHZilla Corp. 1.969M
NovaBay Pharmaceuticals, Inc. 0.042M
Palatin Technologies, Inc. 14.90M